TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,824,145 | -54.4% | 117,915 | -53.7% | 0.00% | -100.0% |
| Q2 2023 | $3,998,195 | +250.8% | 254,500 | +267.9% | 0.00% | – |
| Q1 2023 | $1,139,889 | -94.0% | 69,168 | -94.3% | 0.00% | -100.0% |
| Q4 2022 | $18,887,217 | +576.0% | 1,210,719 | +462.0% | 0.00% | – |
| Q3 2022 | $2,794,000 | -88.3% | 215,425 | -87.4% | 0.00% | -100.0% |
| Q2 2022 | $23,942,000 | -3.5% | 1,705,242 | -1.6% | 0.01% | +50.0% |
| Q1 2022 | $24,820,000 | -36.7% | 1,733,220 | -39.7% | 0.00% | +300.0% |
| Q4 2021 | $39,200,000 | -5.0% | 2,875,930 | +14.2% | 0.00% | -80.0% |
| Q3 2021 | $41,257,000 | -9.0% | 2,518,708 | -6.5% | 0.01% | -16.7% |
| Q2 2021 | $45,338,000 | -44.7% | 2,693,858 | -40.0% | 0.01% | -50.0% |
| Q1 2021 | $82,039,000 | -13.7% | 4,492,885 | -14.0% | 0.01% | +50.0% |
| Q4 2020 | $95,028,000 | +259.3% | 5,221,374 | +252.2% | 0.01% | +60.0% |
| Q3 2020 | $26,449,000 | +3.3% | 1,482,637 | +3.8% | 0.01% | -28.6% |
| Q2 2020 | $25,599,000 | -2.6% | 1,427,687 | -17.5% | 0.01% | -12.5% |
| Q1 2020 | $26,284,000 | -27.2% | 1,731,454 | -5.3% | 0.01% | -20.0% |
| Q4 2019 | $36,086,000 | +9.6% | 1,829,028 | -4.4% | 0.01% | -9.1% |
| Q3 2019 | $32,919,000 | -65.3% | 1,913,938 | -64.3% | 0.01% | -8.3% |
| Q2 2019 | $94,801,000 | +187.5% | 5,355,922 | +230.9% | 0.01% | -14.3% |
| Q1 2019 | $32,974,000 | +1003.9% | 1,618,800 | +811.5% | 0.01% | +1300.0% |
| Q4 2018 | $2,987,000 | – | 177,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |